Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Labelle, A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 48 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Purdon, SE; Malla, A; Labelle, A; Lit, W
      Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    2. Knott, V; Labelle, A; Jones, B; Mahoney, C
      Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment

      SCHIZOPHRENIA RESEARCH
    3. Purdon, SE; Labelle, A; Boulay, L
      Neuropsychological change in schizophrenia after 6 weeks of clozapine

      SCHIZOPHRENIA RESEARCH
    4. Labelle, A; Light, M; Dunbar, F
      Risperidone treatment of outpatients with schizophrenia: No evidence of sex differences in treatment response

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    5. Yamamoto, K; Bloom, D; La, S; Turecki, G; Joober, R; Yamamoto, K; Benkelfat, C; Joober, R; Lalonde, P; Labelle, A; Turecki, G; Rouleau, GA; Joober, R
      Polymorphism in the cell division cycle 45 like gene and schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    6. Joober, R; Benkelfat, C; Lal, S; Bloom, D; Labelle, A; Lalonde, P; Turecki, G; Rozen, R; Rouleau, GA
      Association between the methylenetetrahydrofolate reductase 677C -> T missense mutation and schizophrenia

      MOLECULAR PSYCHIATRY
    7. Bouchard, RH; Merette, C; Pourcher, E; Demers, MF; Villeneuve, J; Roy-Gagnon, MH; Gauthier, Y; Cliche, D; Labelle, A; Filteau, MJ; Roy, MA; Maziade, M
      Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    8. Labelle-Rojoux, A
      Le Musee des Rieurs: Concerning the comic in art

      REVUE D ESTHETIQUE
    9. Joober, R; Toulouse, A; Benkelfat, C; Lal, S; Bloom, D; Labelle, A; Lalonde, P; Turecki, G; Rouleau, GA
      DRD3 and DAT1 genes in schizophrenia: an association study

      JOURNAL OF PSYCHIATRIC RESEARCH
    10. Knott, V; Labelle, A; Jones, B; Mahoney, C
      EEG hemispheric asymmetry as a predictor and correlate of short-term response to clozapine treatment in schizophrenia

      CLINICAL ELECTROENCEPHALOGRAPHY
    11. Purdon, SE; Jones, BDW; Stip, E; Labelle, A; Addington, D; David, SR; Breier, A; Tollefson, GD
      Neuropsychological change in early phase schizophrenia during 12 months oftreatment with olanzapine, risperidone, or haloperidol

      ARCHIVES OF GENERAL PSYCHIATRY
    12. Joober, R; Benkelfat, C; Brisebois, K; Toulouse, A; Turecki, G; Lal, S; Bloom, D; Labelle, A; Lalonde, P; Fortin, D; Alda, M; Palmour, R; Rouleau, GA
      T102C polymorphism in the 5HT(2A) gene and schizophrenia: relation to phenotype and drug response variability

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    13. Knott, V; Mahoney, C; Labelle, A; Ripley, C; Cavazzoni, P; Jones, B
      Event-related potentials in schizophrenic patients during a degraded stimulus version of the visual continuous performance task

      SCHIZOPHRENIA RESEARCH
    14. Labelle, A; Boulay, LJ; Lapierre, YD
      Retention rates in placebo- and nonplacebo-controlled clinical trials of schizophrenia

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    15. Labelle, A; Boulay, LJ
      An attempted suicide using transdermal nicotine patches

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    16. Lapierre, YD; Angus, C; Awad, AG; Saxena, BM; Jones, B; Williamson, P; Vincent, P; Carle, R; Lavallee, YJ; Manchanda, R; Gauthier, B; Wolf, MA; Teehan, MD; Denis, JF; Malla, AK; Oyewumi, LK; Busse, E; Labelle, A; Claesson, L; Grafford, K
      The treatment of negative symptoms: a clinical and methodological study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    17. Joober, R; Benkelfat, C; Toulouse, A; Lafreniere, RGA; Lal, S; Ajroud, S; Turecki, G; Bloom, D; Labelle, A; Lalonde, P; Alda, M; Morgan, K; Palmour, R; Rouleau, GA
      Analysis of 14 CAG repeat-containing genes in schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    18. Joober, R; Benkelfat, C; Brisebois, K; Toulouse, A; Lafreniere, RG; Turecki, G; Lal, S; Bloom, D; Labelle, A; Lalonde, P; Fortin, D; Alda, M; Palmour, R; Rouleau, GA
      Lack of association between the hSKCa3 channel gene CAG polymorphism and schizophrenia

      AMERICAN JOURNAL OF MEDICAL GENETICS
    19. LABELLE A; DEBEAUREPAIRE R; BOULAY LJ; NABER D; JONES BD; BARNES TRE
      A PILOT-STUDY OF THE SAFETY AND TOLERANCE OF SCH-39166 IN PATIENTS WITH SCHIZOPHRENIA

      Journal of psychiatry & neuroscience
    20. HASSELKUS BR; LABELLE A
      DEMENTIA DAY-CARE ENDINGS - THE UNCERTAIN LIMITS OF CARE

      Journal of applied gerontology
    21. Chouinard, G; Kopala, L; Labelle, A; Beauclair, L; Johnson, SV; Singh, KI
      Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    22. NAIR NPV; REINER C; REITERSCHMITT B; RONOVSKY K; VYSSOKI D; BAEKE J; DESSEILLES M; KINDTS P; MESOTTEN F; PEUSKENS J; ADDINGTON D; BARUCH P; BEAUCLAIR L; BLOOM D; BOUCHARD RH; FILTEAU M; JEFFRIES J; JONES B; LABELLE A; MAJOR B; NAIR N; POURCHER E; REMINGTON G; RIPLEY C; TOEWS J; VINCENT P; WOLF M; ZIPURSKY R; CHABANNES JM; COHEN C; DUPUY C; LAGHRISSITHODE F; LOMBERTIE E; LUNACEK S; PAGNON I; PUPESCHI G; VANAMERONGEN A; DEMLING J; EBERT D; HUMMEL MM; MAYER G; RETTERATH P; SEIFERT G; WENNHOLD B; ZINZTSCH I; DELZOMPO M; ARDON J; DRIES P; MEULDIJK R; JEPPESEN I; MAHNFELDT M; NERDRUM T; OSBY U
      THERAPEUTIC EQUIVALENCE OF RISPERIDONE GIVEN ONCE-DAILY AND TWICE-DAILY IN PATIENTS WITH SCHIZOPHRENIA

      Journal of clinical psychopharmacology
    23. JOOBER R; BENKELFAT C; BRISEBOIS K; LAFRENIERE RGA; TURECKI G; LAL S; BLOOM D; LABELLE A; LALONDE P; FORTIN D; ALDA M; MORGAN K; PALMOUR R; ROULEAU GA
      LACK OF ASSOCIATION BETWEEN THE HSKCA3 CHANNEL GENE CAG POLYMORPHISM AND SCHIZOPHRENIA

      American journal of medical genetics
    24. JOOBER R; BENKELFAT C; LAFRENIERE R; LAL S; BLOOM D; LABELLE A; LALONDE P; BRISEBOIS K; TURECKI G; ALDA M; AJROUD S; PALMOUR R; ROULEAU GA
      STEROID RECEPTORS CO-RECEPTORS AND SCHIZOPHRENIA - AN ASSOCIATION STUDY/

      American journal of medical genetics
    25. BENKELFAT C; NISHIZAWA S; KUWABARA H; LAL S; CHOUINARD G; CUMMING P; LABELLE A; JOOBER R; BRUCE K; DIKSIC M; GJEDDE A
      BRAIN DOPA-DECARBOXYLASE (DDC) ACTIVITY IN UNMEDICATED SCHIZOPHRENIC-PATIENTS

      Schizophrenia research
    26. LABELLE A
      THE NEW PHARMACOTHERAPY OF SCHIZOPHRENIA - BREIER,A

      Canadian journal of psychiatry
    27. JOOBER R; BENKELFAT C; LAFRENIERE R; LAL S; LALONDE P; LABELLE A; TURECKI G; PALMOUR R; ALDA M; ROULEAU GA
      CAG REPEAT CONTAINING GENES AND SCHIZOPHRENIA - AN ASSOCIATION STUDY

      American journal of medical genetics
    28. JOOBER R; BENKELFAT C; LAL S; LOPESCENDES I; LALONDE P; BLOOM D; LABELLE A; PALMOUR R; ROULEAU G
      TRANSLATED CAG REPEATS IN SCHIZOPHRENIA

      American journal of medical genetics
    29. JOOBER R; BENKELFAT C; MANDEL JL; LOPESCENDES I; LAL S; LALONDE P; LABELLE A; PALMOUR R; ODRISCOLL G; ROULEAU GA
      POLYGLUTAMIN CONTAINING PROTEINS IN SCHIZOPHRENIA

      Biological psychiatry
    30. ZIMBROFF DL; KANE JM; TAMMINGA CA; DANIEL DG; MACK RJ; WOZNIAK PJ; SEBREE TB; WALLIN BA; KASHKIN KB; ADAN F; AINSLIE G; ALLAN E; ATRI P; BAKER R; BEITMAN B; BROWN G; CANIVE J; CARMAN J; DOTT S; EDWARDS J; FENTON W; FREIDLI J; FUNDERBURG L; ERESHEFSKY L; GLADSON M; HAMILTON J; HAQUE S; HARTFORD J; HORNE R; HOUCK C; JAMPALA C; LABELLE A; LARSON G; LESEM M; LISKOW B; MAKELA E; MOORE N; MORPHY M; POSEVER T; RISCH S; ROTROSEN J; SHEEHAN D; SILVERSTONE P; SWANN A; TAPP A; THOMAS M; VOLAVKA J; VORA S
      CONTROLLED, DOSE-RESPONSE STUDY OF SERTINDOLE AND HALOPERIDOL IN THE TREATMENT OF SCHIZOPHRENIA

      The American journal of psychiatry
    31. PURDON SE; JONES B; LABELLE A; BOULAY L
      NEUROPSYCHOLOGICAL CHANGE TO CLOZAPINE

      Schizophrenia research
    32. LABELLE A; ALDA M; BOULAY L; LAFONTAINE S; PATEL S
      TREATMENT RESPONSE TO HALOPERIDOL AND FAMILY HISTORY

      Schizophrenia research
    33. LABELLE A; DEBEAUREPAIRE R; BOULAY LJ; JONES BD; NABER D; BARNES TRE
      EFFICACY, SAFETY AND TOLERANCE OF A D-1 ANTAGONIST SCH-3966 IN 6 CASES OF ACUTE PSYCHOTIC STATES

      Schizophrenia research
    34. LABELLE A; BOULAY LJ; JONES BD; PATEL S
      EFFICACY OF RISPERIDONE AT LOWER DOSES - A PILOT-STUDY

      Schizophrenia research
    35. VASSEUR L; CLOUTIER C; LABELLE A; DUFF JN; BEAULIEU C; ANSSEAU C
      RESPONSES OF INDICATOR BACTERIA TO FOREST SOIL AMENDED WITH MUNICIPALSEWAGE-SLUDGE FROM AERATED AND NONAERATED PONDS

      Environmental pollution
    36. JOOBER R; ROULEAU G; FON E; LAL S; PALMOUR R; BLOOM D; LABELLE A; BENKELFAT C
      APOLIPOPROTEIN-E GENOTYPE IN SCHIZOPHRENIA

      American journal of medical genetics
    37. ALDA M; AHRENS B; LIT W; DVORAKOVA M; LABELLE A; ZVOLSKY P; JONES B
      AGE-OF-ONSET IN FAMILIAL AND SPORADIC SCHIZOPHRENIA

      Acta psychiatrica Scandinavica
    38. PURDON SE; JONES BDW; LABELLE A
      NEUROPSYCHOLOGICAL VARIABILITY AND TREATMENT RESPONSE IN SCHIZOPHRENIA

      Schizophrenia research
    39. PURDON SE; JONES BDW; ERICKSON D; LABELLE A
      MEASURING RESPONSE TO NOVEL NEUROLEPTIC TREATMENT

      Schizophrenia research
    40. DEBEAUREPAIRE R; LABELLE A; NABER D; JONES BD; BARNES TRE
      AN OPEN TRIAL OF THE D-1 ANTAGONIST SCH-39166 IN 6 CASES OF ACUTE PSYCHOTIC STATES

      Psychopharmacology
    41. MAZIADE M; BASSETT AS; GODBOUT M; HONER WG; JONES B; KENNEDY JL; LABELLE A; MACCIARDI F; MARTINEZ M; MERETTE C; RAYMOND V; ROULEAU G
      GENETICS

      Journal of psychiatry & neuroscience
    42. ALDA M; LIT W; AHRENS B; LABELLE A; ZVOLSKY P; JONES BD; CAMERON P
      AGE-OF-ONSET IN SPORADIC AND FAMILIAL SCHIZOPHRENIA

      Schizophrenia research
    43. PURDON SE; JONES BD; BEGIN L; LABELLE A; MOHR E
      FRONTAL MEDIATION OF NEW LEARNING IN HUNTINGTONS-DISEASE AND SCHIZOPHRENIA

      Schizophrenia research
    44. PURDON SE; LIT W; LABELLE A; JONES BDW
      RISPERIDONE IN THE TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER

      Canadian journal of psychiatry
    45. JONES BD; PURDON SE; LABELLE A; FINLAYSON R
      RISPERIDONE TREATMENT FOR SEVERE NEGATIVE SYMPTOMS

      Canadian journal of psychiatry
    46. LABELLE A; LENTZ F
      THE INTERACTION OF PEDAGOGY AND LANGUAGE PERCEPTIONS IN A MINORITY MILIEU - DIDACTIC REFLECTIONS

      Canadian modern language review
    47. LABELLE A; LAPIERRE YD
      ANXIETY DISORDERS .1. DIAGNOSIS AND TREATMENT

      Canadian family physician
    48. LABELLE A; LAPIERRE YD
      ANXIETY DISORDERS .2. PHARMACOTHERAPY WITH BENZODIAZEPINES

      Canadian family physician


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/02/20 alle ore 09:45:43